A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin

Completed · Phase 1 · Has a placebo group

Conditions studied: Ejaculation

In brief

The purpose of this study is to assess the pharmacodynamics (the actions or effects a drug has on the body), pharmacokinetics (blood levels), safety, and tolerability of dapoxetine 60 mg when concomitantly administered in participants taking terazosin.

Key facts

Study ID
NCT01366664
Run by
Janssen Research & Development, LLC
People needed
24
Starts
2011-04-01
Expected to finish
2012-04-01
Last updated by the study team
2014-10-07

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.